The Birmingham Executive Who Looks Fine on Paper
The executive walks into the office at 7 a.m. with a black coffee and a calendar full of board meetings. He is forty-six, runs three miles two days a week, and weighs the same as he did at thirty. His annual physical was unremarkable. His doctor told him he looks great.
He is also accumulating the kind of fat that does not show up in a mirror, on a scale, or in a standard physical. It sits inside his abdomen, wrapped around his liver, pancreas, and intestines. It is metabolically active in ways subcutaneous fat is not. And it is quietly setting the conditions for the heart attack, stroke, or cognitive decline he assumes is decades away.
This is visceral fat. In Birmingham and Vestavia Hills, the executives, attorneys, surgeons, and operators we work with at Pro Fit High Performance Medicine are often carrying more of it than they realize, and almost none of them have ever measured it.
What Visceral Fat Actually Is
There are two functionally distinct fat compartments in the human body. Subcutaneous fat sits between the skin and the muscle. You can pinch it. It is largely cosmetic and metabolically quiet.
Visceral adipose tissue lives deep inside the abdominal cavity. It surrounds the liver, pancreas, kidneys, and intestines. It is not a passive storage depot. It is a hormonally active endocrine organ that releases inflammatory cytokines, including interleukin-6, TNF-alpha, leptin, and resistin, directly into the portal circulation that feeds the liver first.
That portal drainage matters. Every inflammatory signal visceral fat produces hits the liver before it reaches the rest of the body. Over years, that constant signaling rewires hepatic insulin signaling, drives non-alcoholic fatty liver disease, suppresses adiponectin, and erodes the body’s capacity to handle glucose.
Why BMI and the Bathroom Scale Miss It
Body Mass Index was developed in the 1830s as a population-level statistical tool. It is not a measure of metabolic health, and it was never designed to be one.
A man can carry a normal BMI and have a dangerous quantity of visceral fat. The clinical literature calls this phenotype thin on the outside, fat on the inside, or TOFI. A normal-weight forty-five-year-old executive with a sedentary job, four hours of sleep, chronic stress, and a glass of bourbon every evening can have visceral fat levels that match someone twenty pounds heavier.
The scale measures gravity. It does not measure where fat is stored, what it is doing, or how dangerous it is.
What Visceral Fat Drives
The mechanisms are not theoretical. Visceral adiposity is causally linked to:
- Insulin resistance and progression toward type 2 diabetes
- Elevated ApoB and atherogenic lipoprotein profiles
- Non-alcoholic fatty liver disease
- Systemic chronic inflammation measured by hs-CRP
- Hormonal disruption, including lower testosterone in men and estrogen dominance in women
- Reduced VO2 max and cardiorespiratory fitness
- Higher risk of cardiovascular events, certain cancers, and all-cause mortality
Visceral fat is not a downstream symptom. It is an upstream driver of most of the chronic disease patterns that derail high-performing careers in the second half of life.
The DEXA Scan: How We Actually Measure It
A DEXA scan, or dual-energy X-ray absorptiometry, is the clinical gold standard for measuring visceral adipose tissue in Birmingham performance medicine. The scan takes ten minutes, uses less radiation than a transatlantic flight, and produces three numbers that matter:
- VAT mass in grams or cm squared, the actual quantity of visceral fat
- Lean mass in pounds, which is skeletal muscle, organs, and water
- Bone mineral density, a separate longevity marker
Clinical risk thresholds: under 100 cm squared of VAT is considered low risk. Between 100 and 160 cm squared is the metabolic gray zone. Above 160 cm squared is high cardiometabolic risk regardless of total body weight. Many of the Birmingham executives we scan land in the 130 to 200 cm squared range and have no idea.
A waist-to-height ratio above 0.5 is a reasonable home-screening proxy, but it is not diagnostic. The DEXA is.
Where Visceral Fat Fits in the Pro Fit Performance Continuum
At Pro Fit, every client moves through the same five-phase architecture. We do not skip steps.
- Phase 1, Assessment and Order Labs. DEXA scan, advanced metabolic panel, fasting insulin, hs-CRP, ApoB, sex hormones, thyroid, liver markers, and a continuous glucose monitor when indicated.
- Phase 2, Stabilization and Foundations. Sleep, gut, stress regulation, and protein intake addressed before any advanced therapy. Visceral fat does not respond to peptides if cortisol and insulin are dysregulated.
- Phase 3, Optimization and Performance Medicine. Hormone, peptide, and metabolic protocols built from the data, not a template.
- Phase 4, Monitoring and Adaptation. Repeat DEXA at three and six months. Adjust on the trend, not the symptom.
- Phase 5, Maintenance and Longevity Strategy. Quarterly biomarker tracking. The goal is not to lose visceral fat once. It is to never let it accumulate again.
This is the same architecture that runs underneath our work on insulin resistance, ApoB optimization, and continuous glucose monitoring. Visceral fat is the substrate. The other markers describe what it is doing.
What Actually Reduces Visceral Fat
Three categories of intervention have the strongest evidence:
- Resistance training, two to four sessions per week. Skeletal muscle is the primary disposal site for glucose. Building it is non-negotiable.
- Zone 2 cardiovascular work, three to four hours per week. Trains mitochondria to oxidize fat. Improves insulin sensitivity. Drives visceral fat down before subcutaneous fat.
- Protein-led nutrition with controlled carbohydrate timing. Roughly one gram of protein per pound of lean mass. Concentrate starches around training. Limit alcohol, which preferentially deposits as visceral fat.
In Phase 3, targeted pharmacology, when clinically appropriate, accelerates the process. GLP-1 receptor agonists, growth-hormone-axis peptides, and hormone optimization can pull visceral mass down faster than lifestyle alone, but only when the foundations from Phase 2 are in place.
Capability Changes Everything
Most Birmingham executives we meet are not trying to look different. They are trying to stay sharp through their fifties, sixties, and seventies. They want to be present at their kids’ games, sharp in the boardroom, and capable on the trail at sixty-five.
Visceral fat is one of the clearest measurable threats to that future, and one of the most modifiable. You cannot fix what you do not measure. The DEXA scan is where it starts.
Next Step
Book a Free Consult (Phase Placement) at profithpm.com.
